2024
Immunotherapy utilization patterns in patients with advanced cancer and autoimmune disease
Li H, Huntington S, Gross C, Wang S. Immunotherapy utilization patterns in patients with advanced cancer and autoimmune disease. PLOS ONE 2024, 19: e0300789. PMID: 38625861, PMCID: PMC11020359, DOI: 10.1371/journal.pone.0300789.Peer-Reviewed Original ResearchConceptsAutoimmune diseasesImmunotherapy cycleFirst-lineNon-small cell lung cancerAdvanced cancerFirst-line immunotherapyOverall treatment toleranceCell lung cancerRenal cell carcinomaRetrospective cohort studyAssociated with lower oddsAdvanced melanomaCell carcinomaTreatment toleranceAbsolute contraindicationImmunotherapyConsensus guidelinesImprove cancer survivalLung cancerCohort studyClinical variablesCancer patientsAcademic centersPatientsIncidence rate
2019
Understanding cancer care coordination: Opening the black box.
Canavan M, Sedghi T, Gross C, Lane S, Bogdan J, Adelson K. Understanding cancer care coordination: Opening the black box. Journal Of Clinical Oncology 2019, 37: e18310-e18310. DOI: 10.1200/jco.2019.37.15_suppl.e18310.Peer-Reviewed Original ResearchIndirect patient careCare coordinatorsPatient careAcute care utilizationCare management programSite of careDirect patient careOncology Care ModelElderly patientsMultidisciplinary careTreatment complicationsCare utilizationCancer careSymptom assessmentCare coordinationOutpatient careCare modelCare plansHigh riskAcademic centersNurses' experiencesCancer supportPatientsCareActivity time
2015
Evaluation at Academic Centers Increases the Likelihood of Active Surveillance in Low-Risk Prostate Cancer
Lester-Coll N, Park H, Rutter C, Corso C, Mancini B, Yeboa D, Kim S, Gross C, Yu J. Evaluation at Academic Centers Increases the Likelihood of Active Surveillance in Low-Risk Prostate Cancer. International Journal Of Radiation Oncology • Biology • Physics 2015, 93: s118. DOI: 10.1016/j.ijrobp.2015.07.281.Peer-Reviewed Original Research